To determine whether the LiCl effect seen in the endometrial cancer cell lines was specific to GSK3 inhibition, we tested another GSK3β inhibitor, GSK3β inhibitor VIII [30], and found similar results (Figure 2). Here, GSK3B is linked to endometrial cancer.